The Editor-in-Chief, Dr Pilch, of Drug Design, Development and Therapy has been alerted to unacceptable levels of duplication between a previously published paper: Macciò A, Madeddu C, Mantovani G. Current pharmacotherapy options for cancer anorexia and cachexia. Expert Opin. Pharmacotherapy 2012 13(17) 2453–2472 and one published subsequently in Drug Design, Development and Therapy: Mantovani G, Madeddu C, Macciò A. Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome. Drug Design, Development and Therapy 2013:7 645–656.
. 2013 Nov 21;7:1385. doi: 10.2147/DDDT.S57434
Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome [Retraction]
Collection date 2013.
© 2013 Dove Medical Press. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.
PMCID: PMC3839839 PMID: 24311941
See "Novel purine thioglycoside analogs: synthesis, nanoformulation and biological evaluation in in vitro human liver and breast cancer models" in volume 13 on page 2453.
This retracts the article "Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome" on page 645.